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Cystic fibrosis (CF) airway becomes colonized with only a limited number of bacterial pathogens. It is of paramount importance to
establish in vitro and in vivo models to better understand bacterial–host interactions under CF-like conditions. In this article, in vitro methods
suitable to study Pseudomonas aeruginosa (Pa) and Staphylococcus aureus (Sa) adherence to and uptake by airway epithelial cells are
described. Acute and chronic respiratory infection models, which have been used in CF transgenic mice and mimic human CF lung
pathology, are also taken into consideration.
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Cystic fibrosis (CF) lung disease is caused by chronic
infection of the airways involving few bacterial species:
Pseudomonas aeruginosa (Pa) is the most common isolate,
followed by Staphylococcus aureus (Sa), Haemophilus
influenzae (Hi), Stenotrophomonas maltophilia (Sm) and
Burkholderia cepacia (Bc) [1].
In vitro cellular models may help to dissect the initial
phases of host–pathogen interaction. Bacterial adherence to
and uptake by airway epithelial cells can be studied by
means of simple staining techniques, antibiotic exclusion
assays, and a combination of immunodetection and electron
microscopy (EM). In vivo models are also established1569-1993/$ - see front matter D 2004 European Cystic Fibrosis Society. Publish
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Injection of planktonic bacteria allows us to study their
internalisation by respiratory cells and early clearance from
the airways, while injection of Pa embedded into agarose
beads should be helpful in studying host–pathogen interac-
tion under CF-like conditions.2. In vitro bacterial adherence and uptake assays
2.1. Immunodetection and quantification of bacteria–
airway epithelial cells interaction
The immunodetection of Sa is based on the high affinity
of SpA, a cell wall-associated protein of Sa, for type G
immunoglobulins (IgG) through binding to the Fc fragment.
The main advantage of the immunolabelling methodology
described hereafter is that it does not generate any back-
ground signal, even with a two-step immunolabelling pro-
cedure, which is particularly relevant in a complex context
such as the CF lung. Moreover, the amplification procedure
allows to detect bacteria which poorly express SpA, which
is not possible with a one-step protocol based on a conju-
gated IgG [2,3].
For the immunofluorescence protocol, cell wall-associ-
ated SpA molecules are detected on cryosections of cultureded by Elsevier B.V. All rights reserved.
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IgG followed by streptavidin-Texas Red. When a double
immunolabelling (detection of both bacteria and epithelial
antigens) protocol is performed, after the labelling of
bacteria sections are further incubated with primary mouse
monoclonal antibody (Ab) against cytokeratin (CK)-13, a
typical airway epithelial basal cell marker, followed by
antimouse F(abV)2 fractions coupled with digoxigenin. Sec-
tions are finally incubated with anti-digoxigenin Fab frac-
tions coupled with fluorescein isothiocyanate (FITC).
For the immunoelectron microscopical detection of Sa,
cell wall-associated SpA is detected by fixing cell cultures
in 4% (w/v) paraformaldehyde, followed by incubation with
biotinylated DAR IgG, with a goat antibiotin Ab, and then
with SpA–15-nm gold particle complexes.
The immunodetection of Pa can be easily performed with
commercial sera directed against serotypes of lipopolysac-
charides (LPS) which are routinely used for diagnosis.
Serum against one serotype or a combination of sera
covering all serotypes may be used. Sections are treated
with a mixture of Pa rabbit antisera, with anti-rabbit F(abV)2
fractions coupled with digoxigenin and then with anti-
digoxigenin Fab fraction coupled with FITC.
For quantification of bacterial adherence, cells are fixed
and bacteria can be detected by specific labelling as de-
scribed above. The percentage of cells with adherent bacte-
ria as well as the mean number of adherent bacteria per cell
can be determined by light microscopy, after counterstaining
with Giemsa or Harris hematoxylin.
Bacterial adherence can also be assessed with scanning
electron microscopy (SEM). By using image analysis work-
stations connected to the SEM, it is possible to obtain
topographic information, such as the localization of the object
within a region of interest drawn at any magnification of the
microscope or quantitative data. The major disadvantage of
the method is that only small areas of cell surfaces are
examined. The software has been developed initially for Pa
quantification [4] and further modified for Sa [2]. Thirty-five
fields screening the cell culture can be analyzed at a constant
magnification of 2700 . Bacteria, isolated and in aggregates,
are counted and recorded as the total number of adherent
bacteria per square micrometer of airway epithelial surface.
2.2. Pa and Sa interaction with primary respiratory
epithelial cells in 3-D cultures
The three-dimensional (3-D) cell culture model (‘‘cell
balls’’), as described elsewhere in this supplement [5,6],
provides a good method to study bacteria/eukaryotic cell
interactions for the following reasons: (1) interaction can be
studied with differentiated cells which are representative for
the respiratory tract like mucus secreting goblet cells,
ciliated cells and cells with microvilli; (2) interactions of
bacteria with the cells which influence the ciliary beat
frequency and mucus secretion can be studied; (3) mucus
hyper secretion can be induced by host factors which couldinfluence the bacteria adhesion and invasion; (4) the long
life-time of the cell balls, compared to monolayer cultures of
primary cells, i.e., more than 3 months, allows many
independent experiments and long time studies with mate-
rial from one single patient.
The primary cell culture model described by Jorissen
et al. [7] is used with modifications. After repeated wash-
ings, polyps are digested with 0.1% (w/v) pronase overnight
at 4 jC under continuous rotation. Due to this gentle
digestion, epithelial cell layers are obtained. Cell layers
are washed extensively with culture medium and incubated
for up to 10 days under continuous rotation to avoid cell
adhesion and to facilitate cell ball formation. Later, the cells
are kept at 37 jC under 5% CO2 without shaking for up to 6
months. Cell balls maintain definite epithelial characteristics
of respiratory cells as demonstrated by morphology (polar-
ization, microvilli, tight junctions), positive reactions with
epithelia-specific Abs (anti-CKs), and by a redifferentiation
into a normal respiratory type epithelium with ciliated cells
and mucus-secreting goblet cells [5–8].
To study bacterial adhesion, cell balls are kept in culture
medium depleted of antibiotics and antimycotics for 5 days,
and then incubated with bacteria for 2 h. Cell balls can be
extensively washed prior to incubation with bacteria to
remove secreted mucus. Adhesion of bacteria can be inves-
tigated by scanning electron microscopy (SEM) or by
transmission electron microscopy (TEM) [8].
Alternatively, air– liquid interface (ALI) culture of pri-
mary respiratory cells can be used for these studies [9]. A
method for obtaining ALI cultures can be found on this
supplement and on the webpage of the European Working
Group on CFTR expression [10,11].
2.3. Pa uptake assays
Ingestion of bacteria by respiratory epithelial cells can be
assessed by standard staining techniques. The crystal violet
staining was first described by van Putten et al. [12]. This
technique allows us to distinguish adhered from internalized
bacteria using microscopic analysis. Adhered bacteria stain
homogenously, whereas internalised bacteria present a phago-
cytic vacuole around them. Crystal violet stains bacteria deep
violet, against the faint violet cytoplasm of the eukaryotic cells
as background. Bacteria/cell ratios and incubation times
(generally 1 h or less) have to be assessed according to the
cell type. The crystal violet assay is not informative when
cells to be analysed have a thin layer of cytoplasm.
Endocytosis of bacteria can be also quantitated by the
gentamicin exclusion assay. Respiratory epithelial cells
infected with Pa are incubated with gentamicin. This antibi-
otic does not cross the intact eukaryotic plasma membrane
and therefore kills only adhered bacteria and not internalized
bacteria [13,14]. Cells are grown on 24-well plates and
infected for 1 h. To evaluate the total number of cell-
associated bacteria, cells are further lysed in 0.5% (w/v)
saponin. To evaluate the presence of intracellular bacteria,
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lysed in saponin. Cell lysates are then serially diluted and
plated on tryptic soy agar (TSA) plates. To normalise bacte-
rial counts, control cells are detached and counted using
trypan blue. A limitation of this assay is related to the extent
to which paracellular bacteria, which have been intercalated
between cells in culture, are protected from the drug. Control
experiments with acridine orange staining [15] showed that
paracellular bacteria were alive after gentamicin treatment (E.
Copreni and M. Conese, unpublished results). This assay has
been used to demonstrate that human CF respiratory epithe-
lial cells are defective in the ingestion of Pa and S. typhimu-
rium as compared to non-CF cells [16,17].
Ingestion of bacteria by epithelial cells can be studied
also by electron and confocal microscopy on well-differen-
tiated polarised cells [18,19].3. Pa-induced DNA fragmentation in airway epithelial
cells in culture
Apoptotic response of airway epithelial cells to bacterial
infection can be advantageous for the host or protective for
the bacteria [20]. DNA strand breaks are one of the hall-
marks of apoptosis induced by Pa challenge and can be
studied by different methods, including nuclear staining
with intercalating dyes [21] and immunocytochemical assay
[19]. A quantitative method is based on the detection of
mononucleosomes and oligonucleosomes in the cytoplasmic
fraction of cell lysates by means of a commercial enzyme-
linked immunosorbent assay (ELISA) [22]. The enrichment
of mononucleosomes and oligonucleosomes in the cyto-
plasm of the apoptotic cells is an early event and occurs
several hours before plasma membrane breakdown. To
evaluate these events cells are challenged with bacteria for
4 h and then incubated for an overnight period in the
presence of gentamicin. Bacteria/cell ratios and incubation
times may substantially vary with the bacterial strain and
dosage and cell type. Normalisation is carried out by
counting trypsinised cells from control wells or by protein
determination by standard assays. Evaluation of the apopto-
tic response by this method did not reveal a difference
between cogenic CF and non-CF cells upon challenge with
Pa (E. Copreni and M. Conese, unpublished results), similar
to what was found by Rajan et al. [19], but in contrast to
results recently published by Cannon et al. [23].4. In vivo models of bacterial infection of the airways
4.1. Evaluation of bacterial clearance and internalisation
by airway epithelial cells following intratracheal
administration
To study the interaction between Pa and airway epithelial
cells in vivo during an acute stage of infection, a model oflocal (intratracheal) administration of Pa to the murine lung
has been developed. This model allows to analyse the
bacterial burden at different time intervals and the role of
bacterial internalisation in the clearance process. Mice are
anaesthetised by intraperitoneal injection of freshly prepared
tribromoethanol and placed in dorsal recumbency. The tra-
chea is exposed by ventral midline incision of the skin and
intubated with a sterile flexible 22-g cannula. Bacteria (50 Al)
are inoculated via the cannula into the lung. Nonpyrogenic
phosphate-buffered saline (PBS) is injected intratracheally as
a control and to check for bacterial cross-contaminations. At
different time points after infection, lungs are excised asep-
tically and homogenised in 1 ml sterile PBS. Serial dilutions
are spotted onto TSA plates and colony-forming units (cfu)
are determined after 24 h-growth at 37 jC.
For internalisation studies, lungs are aseptically re-
moved 4 h after the infection and single cell suspensions
are made by forcing the tissue through first a 100-mesh
and then an 80-mesh sterile sieve into tissue culture
medium [24,25]. For determination of the total number
of bacteria in a tissue, 0.5% (w/v) saponin is added to a
measured portion of the single-cell suspension. The num-
ber of intracellular bacteria is determined by centrifuging
another measured portion, resuspending the cells in medi-
um with 10% (v/v) fetal calf serum containing gentamicin,
and incubating the suspension for 1 h. The cells are then
washed three times in medium to remove the antibiotic and
then suspended in medium with 0.5% (w/v) saponin to
release intracellular bacteria. To assess the efficiency of
infection by this route, control experiments should include
quantitation of the bacterial burden immediately after the
bacteria are applied.
The intratracheal administration of planktonic Pa has
been used for studying transgenic CF mice, which show
lower clearance and internalisation than control non-CF
mice [25]. The results obtained may vary according to the
Pa isolate (mucoid or nonmucoid) and the mouse strains
(inbred or outbred) used [26,27].
4.2. Establishment of chronic airway infection established
with agar bead-laden bacteria
The agar beads model is used to achieve a long term (1
month) chronic infection in animal models mimicking to
some extent the histopathology seen in CF lungs [28].
However, variable susceptibility to infection has been also
reported employing different mice strains: BALB/c were
found to be resistant and DBA/2 mice were identified as the
most susceptible strain while C57Bl/6 and A/J mice were
found to be relatively susceptible [29–31]. In addition, CF
mice respond with excessive lung inflammation and in-
creased mortality to chronic bronchopulmonary infection
when compared to wild-type mice [32–35].
To prepare agar bead-laden bacteria, log phase Pa are
concentrated and 1010 bacteria are added to 1.5% TSA. This
mixture is pipetted forcefully into heavy mineral oil at 50
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cooling to 4 jC with continuous stirring. The oil–agar
mixture is centrifuged to sediment the beads and washed
extensively in PBS, pH 7.4. The size of the beads is
microscopically examined and preparations with beads of
100–200 Am in diameter are used as inocula for animal
experiments. The number of bacteria in the beads is deter-
mined by homogenising the bacteria–bead suspension and
plating serial dilutions on blood agar plates.
The procedure for preparing C57Bl/6 mice for the intra-
tracheal injection has been described above in section 4.1. A
50-Al inoculum of an agar bead suspension is spread via the
cannula into the lung. The mice are then maintained under
specific pathogen-free conditions in a ventilated isolator. At
different days postinjection, mice are killed with an over-
dose of carbon dioxide. For quantitative bacteriology,
mouse lungs are excised aseptically and homogenised in 1
ml PBS. Serial dilutions are spotted onto Pseudomonas
Identification Agar plates and cfu determined after 24 h-
growth at 37 jC.5. Conclusions
Overall, the methods described in the foregoing sections
provide the means to assess the nature of the host/pathogen
interaction in respiratory epithelial cell cultures in vitro and
in the lung in vivo. Adherence and uptake assays will
provide data to assess the different types of interactions
which are occurring in vitro, as well as information about
the phagocytic activity of airway-derived epithelial cells
and the fate of ingested bacteria. Finally, in vivo evalua-
tion of bacterial interaction with the respiratory epithelium
in CF transgenic mouse models is necessary to clarify the
importance of CFTR in the internalisation and clearance
process.
Further details of the protocols discussed in this article
can be found on the web site of the European Working
Group on CFTR Expression website [36].Acknowledgements
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